Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.

Jiang H, Hu H, Tong X, Jiang Q, Zhu H, Zhang S.

J Cancer Res Clin Oncol. 2012 Jan;138(1):1-9. doi: 10.1007/s00432-011-1062-5. Epub 2011 Sep 24. Review.

PMID:
21947242
2.

Transcriptional regulation and functional implication of S100P in cancer.

Gibadulinova A, Tothova V, Pastorek J, Pastorekova S.

Amino Acids. 2011 Oct;41(4):885-92. doi: 10.1007/s00726-010-0495-5. Epub 2010 Feb 14. Review.

PMID:
20155429
3.

Key promoter elements involved in transcriptional activation of the cancer-related gene coding for S100P calcium-binding protein.

Gibadulinova A, Oveckova I, Parkkila S, Pastorekova S, Pastorek J.

Oncol Rep. 2008 Aug;20(2):391-6.

PMID:
18636203
4.

S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer.

Tóthová V, Gibadulinová A.

Acta Virol. 2013;57(2):238-46. Review.

PMID:
23600880
5.

Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.

Zhu L, Ito T, Nakahara T, Nagae K, Fuyuno Y, Nakao M, Akahoshi M, Nakagawa R, Tu Y, Uchi H, Furue M.

J Dermatol. 2013 Dec;40(12):973-9. doi: 10.1111/1346-8138.12323. Epub 2013 Dec 4.

PMID:
24303922
6.

S100P: a novel therapeutic target for cancer.

Arumugam T, Logsdon CD.

Amino Acids. 2011 Oct;41(4):893-9. doi: 10.1007/s00726-010-0496-4. Epub 2010 May 28. Review.

7.

The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.

Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T.

Cancer Res. 2007 Sep 15;67(18):8633-42.

8.

Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein.

Tothova V, Isola J, Parkkila S, Kopacek J, Pastorek J, Pastorekova S, Gibadulinova A.

J Cell Biochem. 2011 Nov;112(11):3373-84. doi: 10.1002/jcb.23268.

PMID:
21751241
9.

S100P promotes pancreatic cancer growth, survival, and invasion.

Arumugam T, Simeone DM, Van Golen K, Logsdon CD.

Clin Cancer Res. 2005 Aug 1;11(15):5356-64.

10.

Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.

Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, Shirabe K, Maehara Y, Oda Y.

Am J Surg Pathol. 2011 Apr;35(4):590-8. doi: 10.1097/PAS.0b013e31820ffdf1.

PMID:
21412073
11.

Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration.

Austermann J, Nazmi AR, Müller-Tidow C, Gerke V.

J Biol Chem. 2008 Oct 24;283(43):29331-40. doi: 10.1074/jbc.M806145200. Epub 2008 Aug 25.

12.

Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.

Shen Z, Deng H, Fang Y, Zhu X, Ye GT, Yan L, Liu H, Li G.

Oncotarget. 2015 Aug 21;6(24):20672-84.

13.

Molecular regulation of S100P in human lung adenocarcinomas.

Rehbein G, Simm A, Hofmann HS, Silber RE, Bartling B.

Int J Mol Med. 2008 Jul;22(1):69-77.

PMID:
18575778
14.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
15.

Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.

Jakubícková L, Baráthová M, Pastoreková S, Pastorek J, Gibadulinová A.

Acta Virol. 2005;49(2):133-7.

PMID:
16047742
16.

Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.

Koltzscher M, Neumann C, König S, Gerke V.

Mol Biol Cell. 2003 Jun;14(6):2372-84.

17.

Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines.

Hamada S, Satoh K, Hirota M, Fujibuchi W, Kanno A, Umino J, Ito H, Satoh A, Kikuta K, Kume K, Masamune A, Shimosegawa T.

Cancer Sci. 2009 Jan;100(1):103-10. doi: 10.1111/j.1349-7006.2008.00993.x. Epub 2008 Oct 23.

18.

Heterodimeric interaction and interfaces of S100A1 and S100P.

Wang G, Zhang S, Fernig DG, Spiller D, Martin-Fernandez M, Zhang H, Ding Y, Rao Z, Rudland PS, Barraclough R.

Biochem J. 2004 Aug 15;382(Pt 1):375-83.

19.

Oligomerization and divalent ion binding properties of the S100P protein: a Ca2+/Mg2+-switch model.

Gribenko AV, Makhatadze GI.

J Mol Biol. 1998 Oct 30;283(3):679-94.

PMID:
9784376
20.

S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.

Beissel B, Silva ID, Pesquero JB, Russo J, Schor N, Bellini MH.

Oncol Rep. 2007 Mar;17(3):611-5.

PMID:
17273741

Supplemental Content

Support Center